BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8301979)

  • 1. [Treatment of simultaneous episodes of angina and respiration disorders].
    Lazebnik LB; Lesnia EA; Tereshchenko SN
    Klin Med (Mosk); 1993; 71(5):27-9. PubMed ID: 8301979
    [No Abstract]   [Full Text] [Related]  

  • 2. [Approaches to the personal antianginal therapy. Can we consider nitrosorbide as a drug of choice?].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Klin Med (Mosk); 1994; 72(4):62-4. PubMed ID: 7990387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamic study of the aerosol form of nitrosorbide (isomak)].
    Orlov VA; Zamotaev IP; Venediktova MG; Zavolovskaia LI
    Sov Med; 1991; (2):52-4. PubMed ID: 2057842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prazosin in exercise-induced angina pectoris. An open study of work capacity after a single dose of prazosin, isosorbide dinitrate, atenolol and nifedipine].
    Ellingsen O; Kjekshus J
    Tidsskr Nor Laegeforen; 1984 Mar; 104(9):657-60. PubMed ID: 6729795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of isosorbide dinitrate by intravenous infusion in subjects in hemodynamic equilibrium].
    Cappello C; Fusaro MT; Fontana PL; Gini M; Mattioli G
    Minerva Cardioangiol; 1988; 36(1-2):49-54. PubMed ID: 3386854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Yang NI
    Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin].
    Ol'binskaia LI; Sizova ZhM; Ushakova AV
    Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of nifedipine in association with nitroderivatives and betablocking drugs (author's transl)].
    Aquaro G; Belli R; Rey L; Pavia M; Idone P
    G Ital Cardiol; 1980; 10(10):1340-8. PubMed ID: 7239080
    [No Abstract]   [Full Text] [Related]  

  • 12. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries.
    Bugiardini R; Borghi A; Pozzati A; Ottani F; Morgagni GL; Puddu P
    Am J Cardiol; 1993 Aug; 72(3):343-7. PubMed ID: 8342515
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of action of isosorbide dinitrate.
    Russell RO; Mantle JA; Rogers WJ; Rackley CE
    Chest; 1979 Jan; 75(1):2-4. PubMed ID: 105835
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment.
    Jensen G; Trautner F; Rasmussen S; Hesse B
    Eur J Clin Pharmacol; 1983; 24(2):169-72. PubMed ID: 6840163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antianginal effect of transdermal isosorbide dinitrate (multicenter study)].
    Kékes E
    Orv Hetil; 1994 Oct; 135(44):2421-3. PubMed ID: 7970662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of isosorbide dinitrate and nitroglycerin in patients with angina pectoris].
    Zikmund M; Mayer O; Cepelák V
    Vnitr Lek; 1984 Nov; 30(11):1060-5. PubMed ID: 6440352
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pectanginose boring arrested by inhalation of isosorbide dinitrate (author's transl)].
    Bräuer R; Otto C
    Schweiz Rundsch Med Prax; 1979 Jan; 68(4):117-23. PubMed ID: 760114
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.